Cargando…

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health care providers and patients. Co-use of 3,4-Me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeifman, Richard J., Kettner, Hannes, Pagni, Broc A., Mallard, Austin, Roberts, Daniel E., Erritzoe, David, Ross, Stephen, Carhart-Harris, Robin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444769/ https://www.ncbi.nlm.nih.gov/pubmed/37608057 http://dx.doi.org/10.1038/s41598-023-40856-5

Ejemplares similares

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
por: Gabay, Anthony S., et al.
Publicado: (2018)

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
por: Barba, Tommaso, et al.
Publicado: (2022)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
por: Roseman, Leor, et al.
Publicado: (2014)

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
por: Schartner, Michael M., et al.
Publicado: (2017)

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
por: Forstmann, Matthias, et al.
Publicado: (2023)

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
por: Mans, Keri, et al.
Publicado: (2021)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
por: Singleton, S. Parker, et al.
Publicado: (2022)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression
por: Weiss, Brandon, et al.
Publicado: (2023)

Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment
por: Borissova, Anna, et al.
Publicado: (2020)

The down-scheduling of MDMA and psilocybin(e): Too fast and too soon
por: Kisely, Steve
Publicado: (2023)

Body mass index (BMI) does not predict responses to psilocybin
por: Spriggs, Meg J, et al.
Publicado: (2022)

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
por: Nygart, Victoria Amalie, et al.
Publicado: (2022)

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
por: Zeifman, Richard J., et al.
Publicado: (2020)

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2019)

Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
por: Griffiths, Roland R., et al.
Publicado: (2019)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
por: Müller, Felix, et al.
Publicado: (2022)

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
por: Spriggs, Meg J., et al.
Publicado: (2021)

Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality
por: Jones, Grant M., et al.
Publicado: (2022)

Psychedelics and health behaviour change
por: Teixeira, Pedro J, et al.
Publicado: (2021)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
por: Carhart-Harris, R. L., et al.
Publicado: (2017)

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
por: Shukuroglou, Melissa, et al.
Publicado: (2022)

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
por: Carhart-Harris, Robin L, et al.
Publicado: (2021)

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

LSD alters dynamic integration and segregation in the human brain
por: Luppi, Andrea I., et al.
Publicado: (2021)

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
por: Davis, Alan K, et al.
Publicado: (2021)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
por: Argento, Elena, et al.
Publicado: (2021)

Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
por: Malone, Tara C., et al.
Publicado: (2018)

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
por: Carhart-Harris, Robin L, et al.
Publicado: (2017)

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
por: Straumann, Isabelle, et al.
Publicado: (2023)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
por: Stroud, J. B., et al.
Publicado: (2017)

Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use
por: Hübner, Sebastian, et al.
Publicado: (2021)

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience
por: Lewis, Candace R., et al.
Publicado: (2020)

Dose–response relationships of psilocybin-induced subjective experiences in humans
por: Hirschfeld, Tim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oko54k11ai29m67a6ko6jic6ae